236 related articles for article (PubMed ID: 30655754)
1. Association of BRAF gene and TSHR with cervical lymph node metastasis of papillary thyroid microcarcinoma.
Zhou C; Li J; Wang Y; Xue S; Zhang Y
Oncol Lett; 2019 Jan; 17(1):183-194. PubMed ID: 30655754
[TBL] [Abstract][Full Text] [Related]
2. Relationship between BRAF V600E gene mutation and the clinical and pathologic characteristics of papillary thyroid microcarcinoma.
Ji W; Xie H; Wei B; Shen H; Liu A; Gao Y; Wang L
Int J Clin Exp Pathol; 2019; 12(9):3492-3499. PubMed ID: 31934195
[TBL] [Abstract][Full Text] [Related]
3. Associations of BRAF V600E, clinical pathology and imaging factors with the recurrence rate of papillary thyroid microcarcinoma.
Huang K; Gao N; Bian D; Zhai Q; Yang P; Zhang Y
Exp Ther Med; 2020 Dec; 20(6):243. PubMed ID: 33178341
[TBL] [Abstract][Full Text] [Related]
4. Correlation between the BRAF(v600E) gene mutation and factors influencing the prognosis of papillary thyroid microcarcinoma.
Sun Y; Shi C; Shi T; Yu J; Li Z
Int J Clin Exp Med; 2015; 8(12):22525-8. PubMed ID: 26885238
[TBL] [Abstract][Full Text] [Related]
5. Younger Than 55 Years Old and
Lai Y; Gu Y; Yu M; Deng J
Int J Gen Med; 2023; 16():1403-1414. PubMed ID: 37155469
[TBL] [Abstract][Full Text] [Related]
6. Outcome of papillary thyroid microcarcinoma: Study of 1,990 cases.
Lu ZZ; Zhang Y; Wei SF; Li DS; Zhu QH; Sun SJ; Li M; Li LI
Mol Clin Oncol; 2015 May; 3(3):672-676. PubMed ID: 26137285
[TBL] [Abstract][Full Text] [Related]
7. [Clinical pathological characteristics of resectable papillary thyroid microcarcinoma].
Shi CL; Guo Y; Lyu YC; Nanding ZABYS; Gao WC; Shi TF; Qin HD; Liu SY
Zhonghua Zhong Liu Za Zhi; 2017 May; 39(5):361-366. PubMed ID: 28535653
[No Abstract] [Full Text] [Related]
8. [Invasiveness of papillary thyroid microcarcinoma with BRAF mutation].
Yang X; Liang ZY; Meng C; Liang J; Yu Z; Lin YS
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Aug; 35(4):398-403. PubMed ID: 23987486
[TBL] [Abstract][Full Text] [Related]
9. Deciphering novel biomarkers of lymph node metastasis of thyroid papillary microcarcinoma using proteomic analysis of ultrasound-guided fine-needle aspiration biopsy samples.
Lin P; Yao Z; Sun Y; Li W; Liu Y; Liang K; Liu Y; Qin J; Hou X; Chen L
J Proteomics; 2019 Jul; 204():103414. PubMed ID: 31195151
[TBL] [Abstract][Full Text] [Related]
10. [Correlation between Ultrasound-guided Fine-needle Aspiration Combined with BRAF
Zhang Y; Luo YK; Zhang Y; Zhang MB; Guang Y; Xie F; Jiang B; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Aug; 41(4):517-523. PubMed ID: 31484615
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive evaluation of risk factors for lymph node metastasis in patients with papillary thyroid carcinoma.
Dong Y; Wang D; Luo Y; Chen L; Bai H; Shen Y; Zhang Y; Chen X; Su X; Zhao J; Liu H; Lu J; Yao Z; Zhao Y; He C; Li X
Oncol Lett; 2021 Mar; 21(3):188. PubMed ID: 33574927
[TBL] [Abstract][Full Text] [Related]
12. Co-existence of
Ren H; Shen Y; Hu D; He W; Zhou J; Cao Y; Mao Y; Dou Y; Xiong W; Xiao Q; Zhang Y; Su X
Cancer Manag Res; 2018; 10():1005-1013. PubMed ID: 29760568
[TBL] [Abstract][Full Text] [Related]
13. Association of BRAF
Attia AS; Hussein M; Issa PP; Elnahla A; Farhoud A; Magazine BM; Youssef MR; Aboueisha M; Shama M; Toraih E; Kandil E
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555268
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological Features and Prognosis of Papillary Thyroid Microcarcinoma for Surgery and Relationships with the BRAFV600E Mutational Status and Expression of Angiogenic Factors.
Shi C; Guo Y; Lv Y; Nanding A; Shi T; Qin H; He J
PLoS One; 2016; 11(12):e0167414. PubMed ID: 27936049
[TBL] [Abstract][Full Text] [Related]
15. [Association between BRAF V600E mutation and central lymph node metastasis in patients with papillary thyroid carcinoma].
Shi C; Qin H; Ding C; Sun Y; Lyu Y; Shi T
Zhonghua Zhong Liu Za Zhi; 2015 Feb; 37(2):123-7. PubMed ID: 25975689
[TBL] [Abstract][Full Text] [Related]
16. Predictive Value of Ultrasound Imaging Characteristics and a BRAF V600E Nomogram for Central Lymph Node Metastasis Risk in Papillary Thyroid Microcarcinoma.
Zhu D; Wu X; Zhang L; Chen Z
Altern Ther Health Med; 2023 Nov; 29(8):139-143. PubMed ID: 37632946
[TBL] [Abstract][Full Text] [Related]
17. Preoperative BRAF mutation is predictive of occult contralateral carcinoma in patients with unilateral papillary thyroid microcarcinoma.
Zhou YL; Zhang W; Gao EL; Dai XX; Yang H; Zhang XH; Wang OC
Asian Pac J Cancer Prev; 2012; 13(4):1267-72. PubMed ID: 22799316
[TBL] [Abstract][Full Text] [Related]
18. Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?
Nucera C; Pontecorvi A
Front Endocrinol (Lausanne); 2012; 3():33. PubMed ID: 22649416
[TBL] [Abstract][Full Text] [Related]
19. The contributing factors for lateral neck lymph node metastasis in papillary thyroid microcarcinoma (PTMC).
Kim K; Zheng X; Kim JK; Lee CR; Kang SW; Lee J; Jeong JJ; Nam KH; Chung WY
Endocrine; 2020 Jul; 69(1):149-156. PubMed ID: 32146654
[TBL] [Abstract][Full Text] [Related]
20. Expression of sodium-iodide symporter and TSH receptor in subclinical metastatic lymph nodes of papillary thyroid microcarcinoma.
So YK; Son YI; Baek CH; Jeong HS; Chung MK; Ko YH
Ann Surg Oncol; 2012 Mar; 19(3):990-5. PubMed ID: 21879263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]